A Systematic Review and Meta-Analysis of Therapeutic Efficacy and Safety of Alirocumab and Evolocumab on Familial Hypercholesterolemia

QR Code

A Systematic Review and Meta-Analysis of Therapeutic Efficacy and Safety of Alirocumab and Evolocumab on Familial Hypercholesterolemia

Objectives. The aim of this study was to provide the first study to systematically analyze the efficacy and safety of PCSK9-mAbs in the treatment of familial hypercholesterolemia (FH). Methods. A computer was used to search the electronic Cochrane Library, PubMed/MEDLINE, and Embase databases for cl...

Full description

Saved in:

Bibliographic Details
Main Authors:	Xiaoyue Ge, Tiantian Zhu, Hao Zeng, Xin Yu, Juan Li, Shanshan Xie, Jinjin Wan, Huiyao Yang, Keke Huang, Weifang Zhang
Format:	article
Language:	EN
Published:	Hindawi Limited 2021
Subjects:	Medicine R
Online Access:	https://doaj.org/article/e51a44835611488ab7f48d477e25e3ac
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Beneficial effects of PCSK9 inhibition with alirocumab in familial hypercholesterolemia involve modulation of new immune players
by: Patrice Marques, et al.
Published: (2022)

Therapeutic efficacy and safety of PCSK9-monoclonal antibodies on familial hypercholesterolemia and statin-intolerant patients: A meta-analysis of 15 randomized controlled trials
by: Li Jun Qian, et al.
Published: (2017)

PROPORTION OF PSORIASIS IN FAMILIAL HYPERCHOLESTEROLEMIA
by: Samip Sheth, et al.
Published: (2021)

Therapeutic targets of hypercholesterolemia: HMGCR and LDLR
by: Ma S, et al.
Published: (2019)

The Genetic Spectrum of Familial Hypercholesterolemia (FH) in the Iranian Population
by: R. H. Fairoozy, et al.
Published: (2017)

Erratum: Genetic testing for familial hypercholesterolemia—past, present, and future
by: Marta Futema, et al.
Published: (2021)

A Phase 1, Randomized, Double-Blind, Single-Dose, Placebo-Controlled Safety, Tolerability, And Pharmacokinetic/Pharmacodynamic Study Of Evolocumab In Healthy Chinese Subjects
by: Liu C, et al.
Published: (2019)

Population pharmacokinetics and exposure–response modeling for evinacumab in homozygous familial hypercholesterolemia
by: Xia Pu, et al.
Published: (2021)

Familial Hypercholesterolemia in the Arabian Gulf Region: Clinical results of the Gulf FH Registry.
by: Khalid F Alhabib, et al.
Published: (2021)

Complex Phenotype of Hypercholesterolemia in a Family with Both ABCG8 and APOB Mutations
by: Ana Cristina Ferreira, et al.
Published: (2021)

Subjects with molecularly defined familial hypercholesterolemia or familial defective apoB-100 are not being adequately treated.
by: Trond P Leren, et al.
Published: (2011)

Apolipoprotein B gene mutation related to familial hypercholesterolemia in an Iranian population: With or without hypothyroidism
by: Golnaz Vaseghi, et al.
Published: (2021)

Efficacy and safety of therapeutic plasma exchange in stiff person syndrome
by: Czempik Piotr F., et al.
Published: (2021)

Myocardial fibrosis assessed by magnetic resonance imaging in asymptomatic heterozygous familial hypercholesterolemia: the cholcoeur study
by: Antonio Gallo, et al.
Published: (2021)

Gene therapy in a humanized mouse model of familial hypercholesterolemia leads to marked regression of atherosclerosis.
by: Sadik H Kassim, et al.
Published: (2010)

Effects of Evolocumab Added to Moderate-Intensity Statin Therapy in Chinese Patients With Acute Coronary Syndrome: The EMSIACS Trial Study Protocol
by: Jing Gao, et al.
Published: (2021)

A spotlight on alirocumab in high cardiovascular risk patients with type 2 diabetes and mixed dyslipidemia: a review on the emerging data
by: Rana K, et al.
Published: (2019)

Genetic basis of hypercholesterolemia in adults
by: Seyedmohammad Saadatagah, et al.
Published: (2021)

Effect of LDL cholesterol, statins and presence of mutations on the prevalence of type 2 diabetes in heterozygous familial hypercholesterolemia
by: Elisenda Climent, et al.
Published: (2017)

Analysis of Rare Variants in Genes Related to Lipid Metabolism in Patients with Familial Hypercholesterolemia in Western Siberia (Russia)
by: Elena Shakhtshneider, et al.
Published: (2021)

IMPROVING PRIMARY CARE AWARENESS AND SCREENING OF ADULTS WITH FAMILIAL HYPERCHOLESTEROLEMIA THROUGH AN ONLINE PROVIDER EDUCATIONAL PROGRAM
by: Mary Nametka, et al.
Published: (2021)

Managing hypercholesterolemia and preventing cardiovascular events in elderly and younger Chinese adults: focus on rosuvastatin
by: Wang Z, et al.
Published: (2013)

Vaccine targeting ANGPTL3 ameliorates dyslipidemia and associated diseases in mouse models of obese dyslipidemia and familial hypercholesterolemia
by: Hirotaka Fukami, et al.
Published: (2021)

Critical left main coronary artery stenosis in a patient with homozygous familial hypercholesterolemia and aortic valve replacement
by: Nuri Köse, et al.
Published: (2021)

Correction: A randomized, open-label, parallel, multi-center Phase IV study to compare the efficacy and safety of atorvastatin 10 and 20 mg in high-risk Asian patients with hypercholesterolemia.
by: Ji Bak Kim, et al.
Published: (2021)

Author Correction: Genetic basis of hypercholesterolemia in adults
by: Seyedmohammad Saadatagah, et al.
Published: (2021)

Screening and treatment of familial hypercholesterolemia in a French sample of ambulatory care patients: A retrospective longitudinal cohort study.
by: Jean Ferrières, et al.
Published: (2021)

Efficacy and Safety of Traditional Chinese Medicine Injections for Heart Failure With Reduced Ejection Fraction: A Bayesian Network Meta-Analysis of Randomized Controlled Trials
by: Shanshan Lin, et al.
Published: (2021)

Two years after molecular diagnosis of familial hypercholesterolemia: majority on cholesterol-lowering treatment but a minority reaches treatment goal.
by: Roeland Huijgen, et al.
Published: (2010)

Data mining: traditional spring festival associated with hypercholesterolemia
by: Danchen Wang, et al.
Published: (2021)

Family Safety & Health

The Efficacy, Safety and Tolerability of Canakinumab in the Treatment of Familial Mediterranean Fever: A Systematic Review of the Literature
by: Kacar M, et al.
Published: (2020)

Evaluating the Safety, Efficacy, and Therapeutic Potential of Momelotinib in the Treatment of Intermediate/High-Risk Myelofibrosis: Evidence to Date
by: Bassiony S, et al.
Published: (2020)

Maternal supraphysiological hypercholesterolemia associates with endothelial dysfunction of the placental microvasculature
by: Bárbara Fuenzalida, et al.
Published: (2018)

The Sensimed Triggerfish contact lens sensor: efficacy, safety, and patient perspectives
by: Dunbar GE, et al.
Published: (2017)

Efficacy, acceptability, and safety of adjunctive aripiprazole in treatment-resistant depression: a meta-analysis of randomized controlled trials
by: Luan SX, et al.
Published: (2018)

The safety and efficacy of xanthan gum-based thickeners and their effect in modifying bolus rheology in the therapeutic medical management of dysphagia
by: Enrico K. Hadde, et al.
Published: (2021)

Efficacy and safety of olanzapine/fluoxetine combination in the treatment of treatment-resistant depression: a meta-analysis of randomized controlled trials
by: Luan S, et al.
Published: (2017)

The Safety and Efficacy of Weighted Baseballs
by: Michael M Reinold, et al.
Published: (2021)

Glibenclamide - profile of efficacy and safety
by: Lyudmila Viktorovna Nedosugova
Published: (2011)